Reuters - Video

エディション: US | UK | IN | CN | JP

video

Gilead's remdesivir gets conditional EU clearance

2020年 7月 4日 Saturday - 01:00

The European Commission said Friday it had given conditional approval for the use of antiviral drug remdesivir in severe COVID-19 patients. As Fred Katayama reports, that makes it the region's first authorized therapy to treat the virus.

▲ ストーリーを隠す

ストーリーを表示する

The European Commission said Friday it had given conditional approval for the use of antiviral drug remdesivir in severe COVID-19 patients. As Fred Katayama reports, that makes it the region's first authorized therapy to treat the virus.

リンクをコピーするには:URL上で右クリック後「コピー」を選択。モバイル端末では、URLを長押ししてください。

Gilead's remdesivir gets conditional EU clearance

2020年 7月 4日 Saturday - 01:00